Iridian Asset Management LLC Charles River Laboratories International, Inc. Transaction History
Iridian Asset Management LLC
- $422 Million
- Q2 2024
A detailed history of Iridian Asset Management LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Iridian Asset Management LLC holds 46,167 shares of CRL stock, worth $9.16 Million. This represents 2.26% of its overall portfolio holdings.
Number of Shares
46,167
Previous 24,404
89.18%
Holding current value
$9.16 Million
Previous $6.61 Million
44.24%
% of portfolio
2.26%
Previous 1.33%
Shares
19 transactions
Others Institutions Holding CRL
# of Institutions
732Shares Held
51.8MCall Options Held
233KPut Options Held
236K-
Vanguard Group Inc Valley Forge, PA6.1MShares$1.21 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$1.01 Billion0.02% of portfolio
-
State Street Corp Boston, MA2.09MShares$414 Million0.02% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.91MShares$379 Million0.99% of portfolio
-
Clearbridge Investments, LLC New York, NY1.37MShares$272 Million0.24% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $10.1B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...